Reaction
Myopia reporting signals
As of the last recalculation, Myopia appears in 2,341 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is TOPIRAMATE (PRR 33.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Topiramate | 303 | 33.1 | 33.2 |
| Valproate Sodium | 73 | 32.4 | 32.5 |
| Atovaquone | 9 | 10.0 | 10.0 |
| Faricimab | 9 | 9.9 | 9.9 |
| Ranibizumab | 29 | 9.8 | 9.8 |
| Ribociclib | 29 | 8.3 | 8.3 |
| Dorzolamide Hydrochloride And Timolol Maleate | 7 | 7.9 | 7.9 |
| Ketoprofen | 11 | 7.5 | 7.5 |
| Brinzolamide | 7 | 7.2 | 7.2 |
| Fexofenadine Hcl | 7 | 6.7 | 6.8 |
| Aripiprazole Oral | 31 | 6.7 | 6.7 |
| Aripiprazole Orally Disintegrating | 31 | 6.7 | 6.7 |
| Timolol Maleate | 7 | 6.3 | 6.3 |
| Leucovorin Calcium | 13 | 6.1 | 6.1 |
| Zonisamide | 10 | 6.0 | 6.0 |
| Etonogestrel And Ethinyl Estradiol | 14 | 5.6 | 5.6 |
| Rifampin | 9 | 5.5 | 5.5 |
| Insulin Human | 24 | 5.4 | 5.4 |
| Lamivudine Oral | 15 | 5.3 | 5.3 |
| Lumacaftor And Ivacaftor | 5 | 5.2 | 5.2 |
| Sumatriptan | 22 | 5.2 | 5.2 |
| Valproic Acid | 18 | 5.1 | 5.1 |
| Brimonidine Tartrate | 10 | 5.0 | 5.0 |
| Latanoprost | 27 | 4.8 | 4.8 |
| Fingolimod Hcl | 45 | 4.7 | 4.7 |
| Insulin Degludec | 12 | 4.6 | 4.6 |
| Isotretinoin | 25 | 4.5 | 4.5 |
| Timolol | 6 | 4.4 | 4.4 |
| Ado-Trastuzumab Emtansine | 4 | 4.2 | 4.2 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 4.1 | 4.1 |
| Insulin Lispro | 61 | 4.0 | 4.0 |
| Lifitegrast | 7 | 3.8 | 3.8 |
| Vemurafenib | 5 | 3.7 | 3.7 |
| Travoprost | 3 | 3.1 | 3.1 |
| Vigabatrin | 3 | 1.8 | 1.8 |
| Aflibercept | 6 | 1.7 | 1.7 |
| Somatropin | 14 | 1.7 | 1.7 |
| Dupilumab | 65 | 1.2 | 1.2 |